Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
Biological Dynamics, a company developing its exosome-isolation ExoVerita platform for early disease diagnostics, announced it has received IRB approval and will soon begin to...
Journey Biosciences, Inc., a biotechnology company offering biomarker-based predictive risk screening technologies for diabetes-related complications, announced the launch of its flagship product NaviDKD.
NaviDKD, a...
NEOconcepts, a leading distributor of aesthetic medical devices for dermatologists, plastic surgeons, and other medical aesthetic providers, has signed an exclusive agreement with Triworks,...
The phase 3 trial results for lecanemab and gantenerumab presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference demonstrate why optimal treatment of...
